Letter to the Editor. Outcome of malignant meningioma

Zong-Yu YuTri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan

Search for other papers by Zong-Yu Yu in
Current site
Google Scholar
PubMed
Close
,
Ming-Hsuan ChungTri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan

Search for other papers by Ming-Hsuan Chung in
Current site
Google Scholar
PubMed
Close
 MD
,
Peng-Wei WangTri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan

Search for other papers by Peng-Wei Wang in
Current site
Google Scholar
PubMed
Close
 MD
,
Yi-Chieh WuTri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan

Search for other papers by Yi-Chieh Wu in
Current site
Google Scholar
PubMed
Close
 MD
,
Hsiang-Chih LiaoTri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan

Search for other papers by Hsiang-Chih Liao in
Current site
Google Scholar
PubMed
Close
 MD
, and
Dueng-Yuan HuengTri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan

Search for other papers by Dueng-Yuan Hueng in
Current site
Google Scholar
PubMed
Close
 MD, PhD
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $525.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $624.00
USD  $45.00
USD  $525.00
USD  $624.00
Print or Print + Online Sign in
  • Collapse
  • Expand

Illustration from Xu et al. (pp 1418–1430). With permission from Juan Carlos Fernandez-Miranda and The Neurosurgical Atlas by Aaron Cohen-Gadol.

  • 1

    Maier AD, Mirian C, Haslund-Vinding J, et al. Granular clinical history and outcome in 51 patients with primary and secondary malignant meningioma. J Neurosurg. Published online March 11, 2022. doi: 10.3171/2022.1.JNS212723

    • Search Google Scholar
    • Export Citation
  • 2

    Kim D, Niemierko A, Hwang WL, et al. Histopathological prognostic factors of recurrence following definitive therapy for atypical and malignant meningiomas. J Neurosurg. 2018;128(4):11231132.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3

    Hueng DY, Sytwu HK, Huang SM, Chang C, Ma HI. Isolation and characterization of tumor stem-like cells from human meningiomas. J Neurooncol. 2011;104(1):4553.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4

    Lin BJ, Chou KN, Kao HW, et al. Correlation between magnetic resonance imaging grading and pathological grading in meningioma. J Neurosurg. 2014;121(5):12011208.

  • 5

    Lin MC, Li CZ, Hsieh CC, et al. Preoperative grading of intracranial meningioma by magnetic resonance spectroscopy (1H-MRS). PLoS One. 2018;13(11):e0207612.

  • 1

    Maier AD, Stenman A, Svahn F, et al. TERT promoter mutations in primary and secondary WHO grade III meningioma. Brain Pathol. 2021;31(1):6169.

  • 2

    Daniela Maier A, Brøchner CB, Bartek J Jr, et al. Mitotic and proliferative indices in WHO grade III meningioma. Cancers (Basel). 2020;12(11):3351.

  • 3

    Maier AD, Mirian C, Bartek J Jr, et al. Expression of the stem cell marker CD133 in malignant meningioma. Clin Neuropathol. 2020;40(3):151159.

  • 4

    Lin BJ, Chou KN, Kao HW, et al. Correlation between magnetic resonance imaging grading and pathological grading in meningioma. J Neurosurg. 2014;121(5):12011208.

  • 5

    Lin MC, Li CZ, Hsieh CC, et al. Preoperative grading of intracranial meningioma by magnetic resonance spectroscopy (1H-MRS). PLoS One. 2018;13(11):e0207612.

  • 6

    Haslund-Vinding J, Skjoth-Rasmussen J, Poulsgaard L, et al. Proposal of a new grading system for meningioma resection: the Copenhagen Protocol. Acta Neurochir (Wien). 2022;164(1):229238.

    • Crossref
    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 670 670 176
Full Text Views 36 36 6
PDF Downloads 43 43 10
EPUB Downloads 0 0 0